Aprea Therapeutics Management
Management criteria checks 2/4
Aprea Therapeutics' CEO is Oren Gilad, appointed in Jan 2011, has a tenure of 13.83 years. total yearly compensation is $877.43K, comprised of 62.7% salary and 37.3% bonuses, including company stock and options. directly owns 5.96% of the company’s shares, worth $943.17K. The average tenure of the management team and the board of directors is 3.2 years and 3.5 years respectively.
Key information
Oren Gilad
Chief executive officer
US$877.4k
Total compensation
| CEO salary percentage | 62.7% |
| CEO tenure | 13.8yrs |
| CEO ownership | 6.0% |
| Management average tenure | 3.2yrs |
| Board average tenure | 3.5yrs |
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | -US$14m |
| Jun 30 2024 | n/a | n/a | -US$13m |
| Mar 31 2024 | n/a | n/a | -US$13m |
| Dec 31 2023 | US$877k | US$550k | -US$14m |
| Sep 30 2023 | n/a | n/a | -US$13m |
| Jun 30 2023 | n/a | n/a | -US$14m |
| Mar 31 2023 | n/a | n/a | -US$109m |
| Dec 31 2022 | US$753k | US$324k | -US$113m |
Compensation vs Market: Oren's total compensation ($USD877.43K) is above average for companies of similar size in the US market ($USD647.72K).
Compensation vs Earnings: Oren's compensation has increased whilst the company is unprofitable.
CEO
Oren Gilad (56 yo)
13.8yrs
Tenure
US$877,430
Compensation
Dr. Oren Gilad, Ph.D. is Co-Founder of Aprea Therapeutics, Inc (formerly known as Atrin Pharmaceuticals LLC) since 2011 and serves as its Chief Executive Officer since July 2022. Dr. Gilad serves as Presid...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Co-Founder | 13.8yrs | US$877.43k | 5.96% $ 943.2k | |
| Senior VP | 1.8yrs | US$941.36k | 0.13% $ 20.4k | |
| Head of Technology | 7.8yrs | no data | no data | |
| Senior VP & Chief Scientific Officer | 10.1yrs | no data | no data | |
| Senior Vice President of Corporate Development & Strategy | less than a year | no data | no data | |
| Head of Pharmacology Development | 6.8yrs | no data | no data | |
| Chief Business Advisor | 2.5yrs | no data | no data | |
| Executive Officer | less than a year | no data | no data | |
| Controller | 3.2yrs | no data | no data |
3.2yrs
Average Tenure
60yo
Average Age
Experienced Management: APRE's management team is considered experienced (3.2 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Co-Founder | 2.5yrs | US$877.43k | 5.96% $ 943.2k | |
| Independent Director | 9.8yrs | US$58.73k | 0.80% $ 127.1k | |
| Independent Director | 5.3yrs | US$86.23k | 0.14% $ 22.2k | |
| Independent Director | 2.5yrs | US$57.23k | 0.31% $ 49.4k | |
| Independent Director | 2.5yrs | US$53.23k | 4.29% $ 678.6k | |
| Scientific & Clinical Advisory Board Member | 5.8yrs | no data | no data | |
| Independent Chairperson of the Board | 4.4yrs | US$61.16k | 0.0097% $ 1.5k | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Independent Director | 2.5yrs | US$62.73k | 0.0055% $ 869.9 | |
| Scientific & Clinical Advisory Board Member | no data | no data | no data | |
| Scientific & Clinical Advisory Board | no data | no data | no data | |
| Scientific & Clinical Advisory Board Member | no data | no data | no data |
3.5yrs
Average Tenure
64yo
Average Age
Experienced Board: APRE's board of directors are considered experienced (3.5 years average tenure).